Translational Development Acquisition Corp. Ordinary Shares (TDAC)
Official siteFINANCIAL SERVICES • SHELL COMPANIES • NASDAQ
Market Cap: $209.69M
Last updated: Nov 17, 2026 at 4:10 PM ET
Translational Development Acquisition Corp. Ordinary Shares (TDAC) Statistics
Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a market cap of $209.69M and an enterprise value of $211.76M. Its share count is down 11.86% from a year earlier.
Total Valuation
Enterprise value is 0.98% above the market cap, as debt exceeds cash.
| Market Cap | $209.69M |
|---|---|
| Enterprise Value | $211.76M |
| Latest price (Nov 17, 2026) | $10.85 |
Key Dates
| Last Earnings Date | Aug 14, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is up 4.03% over 52 weeks and trades at its 50-day average.
| Beta (1Y) | 0.04 |
|---|---|
| 52-Week Change | +4.03% |
| 1-Month Change | +0.37% |
| 3-Month Change | +0.05% |
| 6-Month Change | +1.97% |
| Total Return (1Y) | +4.03% |
| Return vs SPY (1Y) | -7.53% |
| Max Drawdown (1Y) | -0.92% |
| Sharpe Ratio (1Y) | 1.54 |
| Correlation with SPY (1Y) | 0.21 |
| 50-Day Average | $10.85 |
| 200-Day Average | $10.72 |
| 52-Week Range | $10.41 to $10.95 |
| RSI (14 Days) | 49.0 |
| Average Volume (20 Days) | 18.33K |
Financial Position
Current assets cover 0.03x current liabilities.
| Current Ratio | 0.03x |
|---|---|
| Quick Ratio | 0.03x |
Returns and Efficiency
Return on invested capital is 55.63% over the last 12 months.
| Return on Assets (ROA) | -3.40% |
|---|---|
| Return on Invested Capital (ROIC) | 55.63% |
Scores
TDAC has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was -$553.29K over the last 12 months.
| Revenue | -$553.29K |
|---|---|
| Gross Profit | -$23.22K |
| Operating Income | -$1.65M |
| Pretax Income | -$5.42M |
| Net Income | -$5.42M |
| Reported EPS (TTM) | $0.26 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $85.85K |
|---|---|
| Total Debt | $2.15M |
| Net Debt | $2.06M |
| Net Debt Per Share | $0.11 |
| Working Capital | -$2.80M |
| Shareholder Equity | -$19.03M |
| Total Assets | $159.41M |
| Total Liabilities | $19.12M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$1.14M |
|---|---|
| FCF Per Share | -$0.06 |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
TDAC does not pay a dividend.
| Earnings Yield | 2.38% |
|---|---|
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.04% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About TDAC
What is TDAC's market cap?
Translational Development Acquisition Corp. Ordinary Shares has a market cap of $209.69M. Its enterprise value, which adds debt and subtracts cash, is $211.76M.
What is TDAC's P/E ratio?
Translational Development Acquisition Corp. Ordinary Shares has a trailing P/E ratio of 42.1x.
How many shares of TDAC are outstanding?
Translational Development Acquisition Corp. Ordinary Shares has 19.31M shares outstanding. The count is down 11.86% from a year earlier.
Does TDAC pay a dividend?
No. Translational Development Acquisition Corp. Ordinary Shares does not pay a dividend.
How much debt does TDAC have?
Translational Development Acquisition Corp. Ordinary Shares has $2.15M of total debt and $85.85K of cash and equivalents, a net debt position of $2.06M.
TDAC pages: Overview, Statistics